Madrigal, CSPC sign licensing agreement for oral GLP-1 agonist
CSPC will receive an upfront payment of $120m and could earn up to $2bn in milestone payments, alongside royalties on net sales.
A leading resource for the Pharmaceutical industry since 2002
CSPC will receive an upfront payment of $120m and could earn up to $2bn in milestone payments, alongside royalties on net sales.
Give your business an edge with our leading industry insights.